PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Clinical trials for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) explained in plain language.
Never miss a new study
Get alerted when new PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) trials appear
Sign up with your email to follow new studies for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study follows 300 people with blocked leg arteries who received a treatment using a balloon coated with paclitaxel and vitamin E. The goal is to see if the balloon keeps the artery open and prevents the need for repeat procedures over one year. Participants are adults with m…
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New balloon treatment for blocked leg arteries tested in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study is tracking 200 people with blocked leg arteries who are receiving a special balloon coated with the drug paclitaxel (GENOSS PCB). The balloon is inflated inside the artery to open it and release the drug, which helps prevent the artery from narrowing again. Researcher…
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC